In improving the management of prostate cancer, cryotherapy, interstitial laser ablation and high intensity focused ultrasound may prove to be preferable to radical prostatectomy. For patients with advanced, metastatic or recurrent disease, the mainstay of therapy is likely to remain combined androgen blockade, that is the use of a luteinising hormone-releasing hormone analogue and antiandrogen combination. Other possible new therapeutic advances include the use of growth factor inhibitors such as suramin in hormone escaped prostate cancer and the use of gene therapy. In conclusion,the best hopes for managing prostate cancer lie in earlier detection of the disease,and there is a need for improved diagnostic indicators. It is also important,as a general principle, to increase the efficacy and reduce the morbidity of therapies. However, increased survival is not the only issue as improvements in quality of life are fundamental in patients with prostate cancer.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.